EDP-305

Overview

EDP-305 is an orally active, potent and selective farnesoid X receptor ( FXR ) agonist, with EC 50 values of 34 nM (chimeric FXR in CHO cells) and 8 nM (full-length FXR in HEK cells). EDP-305 shows a potent and consistent antifibrotic effect. EDP-305 can be used for primary biliary cholangitis (PBC) and non-alcoholic steatohepatitis (NASH) research.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Digestive System Inflammation | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > FXR | Products > Signaling Pathways > Phosphatase | Products > Signaling Pathways > Cytochrome P450

Product Information

• Catalog No.: HY-134988
• CAS No.: 1933507-63-1
• Molecular Formula: C36H58N2O5S
• Molecular Weight: 630.92
• Purity: 96.02%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 2.5 mg/mL (3.96 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source